ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0%

Fri, 23 Oct

ALEMBIC PHARMA has announced its results for the quarter ended September 2020. Here is a detailed performance review of the same:

ALEMBIC PHARMA Quarterly Financials

No. of Mths Qtr. Ending		3 Sep-19*	3 Jun-20*	3 Sep-20*	QoQ Change	YoY Change
Net Sales	Rs m	12,409	13,413	14,571	8.6%	17.4%
Other income	Rs m	4	3	32	904.7%	790.6%
Turnover	Rs m	12,412	13,416	14,603	8.8%	17.7%
Expenses	Rs m	8,954	9,340	10,137	8.5%	13.2%
Gross profit	Rs m	3,455	4,074	4,434	8.9%	28.3%
Depreciation	Rs m	360	415	438	5.5%	21.8%
Interest	Rs m	71	67	45	-32.8%	-36.7%
Profit before tax	Rs m	3,029	3,595	3,984	10.8%	31.5%
Tax	Rs m	525	668	730	9.3%	39.0%
Profit after tax	Rs m	2,504	2,927	3,254	11.2%	30.0%
Gross profit margin	%	27.8	30.4	30.4
Effective tax rate	%	17.3	18.6	18.3
Net profit margin	%	20.2	21.8	22.3

Year-on-Year Performance:

• The company's operating income during the quarter grew 17.4% on a year-on-year (YoY) basis. The expenses were up by 13.2% YoY during the same period.
• The company's operating profit increased by 28.3% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 30.4% in 2QFY21 as against 27.8% in 2QFY20.
• Depreciation charges increased by 21.8% and finance costs declined by 36.7% YoY, respectively.
• Other income increased by 790.6% YoY during the quarter.
• Net profit for the quarter increased by 30.0% YoY. Net profit margins during the quarter increased from 20.2% in 2QFY20 to 22.3% in 2QFY21.

Quarter-on-Quarter Performance:

• The company's operating income during the quarter grew 8.6% on a quarter-on-quarter (QoQ) basis. The expenses were up by 8.5% QoQ during the same period.
• The company's operating profit increased by 8.9% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 30.4% in 2QFY21 as against 30.4% in 1QFY20.
• Net profit for the quarter increased by 11.2% QoQ, while net profit margins increased from 21.8% in 1QFY20 to 22.3% in 2QFY21.

To see how ALEMBIC PHARMA has performed over the last eight quarters,please visit here.

UNLOCKED: Up to 3x More Gains During the Corona Crisis...

ALEMBIC PHARMA Share Price Performance

Over the last one year, ALEMBIC PHARMA share price has moved up from Rs 537.2 to Rs 994.2, registering a Gain of Rs 457.0 or around 85.1%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 19,770.1 (up 0.5%). Over the last one year it has moved up from 12,860.6 to 19,770.1, a gain of 6,910 points (up 53.7%).

Overall, the S&P BSE SENSEX is up 4.5% over the year.

Current Valuations

At the current price of Rs 994.2, the price to earnings (P/E) ratio of ALEMBIC PHARMA stands at 17.9 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 6.9 times.